In honor of the 35th anniversary of the Tegaderm™ brand, 3M is celebrating 35 clinicians, thought leaders and pioneers who have positively impacted patient outcomes around the world. We’re calling them the Tegaderm™ Brand 35 to Know.
This week, we recognize Mary Duncan, RN, MSN, CIC, for leading initiatives to improve patient safety and outcomes in vascular access.
Duncan is an infection prevention expert and change agent who employs innovative approaches to dramatically decrease central-line associated bloodstream infections (CLABSIs) in the facilities where she has worked.
Duncan recently conducted a study regarding the creation of a peripheral IV maintenance bundle. After the care bundle was rolled out at one facility, Duncan’s team achieved amazing results — reducing peripheral IV complications by 80 percent.
In addition to her success in infection reduction, Duncan has been actively involved in emergency management, co-chairing an influenza taskforce during the H1N1 outbreak and participating in a multi-disciplinary team to manage patients during the Ebola outbreak.
According to Duncan, the importance of education, identification of appropriate personal protective equipment and vaccination prioritization pushed infection prevention to the forefront of disaster preparation and management.
As a respected thought leader, Duncan has participated on several national infection reduction committees and developed recommendations for a prestigious report.
To learn more about how you can prevent bloodstream infections, visit 3M.com/IVProtect.